Radiotherapy Market

The global radiotherapy market in terms of revenue was estimated to be worth $6.9 billion in 2023 and is poised to reach $8.8 billion by 2028, growing at a CAGR of 5.0% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth of this market is influenced by factors such as increasing incidence of cancer globally, and continuous technological advancements such as development of MRI linear accelerators, proton therapy, introduction of treatment planning software that integrates with imaging data. All these innovations have enhanced the overall cancer treatment outcome. Moreover, increased awareness about early detection of tumours and availability of advanced radiotherapy treatment and ongoing investments by government in the procurement of advanced radiotherapy technologies and establishment of new cancer treatment centers across developing nations are anticipated to play a significant role in accelerating the radiotherapy market during the forecast period.

Additionally, growing collaboration & partnerships among industry players, cancer treatment centers, and oncology research institutes are contributing towards the expansion of radiotherapy services globally, which is further expected to boost the market growth.

However, high cost of obtaining & implementation of radiotherapy devices, especially in the emerging countries lacking adequate funds and healthcare infrastructure are likely to limit the adoption of new radiotherapy technologies. Also, shortage of qualified radiotherapist and oncologist and complexities linked with radiotherapy treatment are the factors expected to restrain the growth of this market during the forecast period.

Global Radiotherapy Market Trends

To know about the assumptions considered for the study, Request for Free Sample Report

e- Estimated; p- Projected

Radiotherapy Market Dynamics

Driver: Technological advancements in radiotherapy treatment

Radiotherapy industry is undergoing a technology-driven revolution. The incorporation of cutting edge technology , such as precision treatment delivery systems including intensity modulated radiation therapy (IMR), stereotactic body radiation therapy (SBRT) delivering precise dose of radiation to cancer cell , the development of MRI LINAC proving real time imaging during treatment, utilization of AI for treatment planning to analysis are playing a significant role in optimizing the radiotherapy treatment process. Industry players are focusing on the introduction of new radiotherapy technologies . For instance:

• In May 2022, Elekta (Sweden) launched Elekta Espirit which is a next-generation Gamma Knife to enable more personalized radiosurgery. The system is yet to receive FDA and CE clearance.
• In May 2022, MagnetTx Oncology Solutions Ltd. (Canada) received clearance from the FDA for its Aurora-RT, a LINAC-MR technology

Such technological advancements focus on improving the functionality of radiotherapy delivery systems and expanding their application areas. The growing adoption of these advanced radiothery systems among cancer treatment centers are likely to drive the growth of the radiotherapy market.

Restraint: lack of adequate healthcare infrastructure in emerging countries

Emerging and underdeveloped economies may face constraints in allocating adequate funds for healthcare infrastructure. The lack of investments and inability to establish radiotherapy facilities can limit the patient accessibility for treatment and slow down the adoption advanced radiotherapy technologies.

Opportunity: Rising Healthcare Expenditure Across Developing Countries

The rapid economic growth observed in developing countries such as China, India are expected to offer a significant growth opportunity for radiotherapy market. Rapid growth in per-capita healthcare expenditure, rising focus of governments across these countries in enhancing healthcare facilities and offering healthcare services are playing a significant role in boosting the market growth. Moreover, the increasing cancer patient population, growing awareness, and increase affordability of healthcare services are likely to fuel the radiotherapy market. Manufacturers of radiotherapy equipment are seeking partnerships with healthcare providers in these countries with an aim expand their market presence. All these factors are anticipated to contribute towards the rapid growth of market in these countries.

Challenge: Risk of Radiation Exposure

One of the major challenges associated with the use of radiation therapy for cancer treatment is the risk of radiation exposure to the healthy tissues. The risk of radiation exposure is more with HDR brachytherapy and systemic radiotherapy (including higher risk of injury to the focused area of tissue), as these include the use of strong doses per cycle. Also, the use of applicators and after loaders during brachytherapy poses a risk of radiation exposure to the technical and supporting staff in case of manual loading and removal of sources. These are the major factors limiting the widespread use of these products.

Market Ecosystem

Based on type, the product segment, held the largest share of radiotherapy industry in 2022

Based on type, the radiotherapy market is segmented into products and software & services. The product segment accounted for the largest share of market in 2022. This is attributed to the higher installed based of radiotherapy devices, increasing prevalence of cancer, and the growing demand for comprehensive cancer care.

Based on technology, the external beam radiotherapy segment, held the largest share of radiotherapy industry in 2022

Based on technology, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy. The external beam radiotherapy segment is further divided into linear accelerators, particle therapy systems, and conventional cobalt-60 teletherapy units. The internal beam radiotherapy/brachytherapy segment includes seeds, applicators, afterloaders, and IORT systems, while the systemic radiotherapy segment includes iobenguane (I-131), samarium-153, rhenium-186, and other radioisotopes.

In 2022, the external beam radiotherapy segment (EBRT) accounted for the largest market share radiotherapy market. External beam radiotherapy is widely and well-established cancer treatment modality, moreover, the high effectiveness of EBRT across various cancer, non-invasive nature of treatment and ongoing technological advancements in external beam radiotherapy such as development of newer techniques such as stereotactic radiosurgery and IMRT to deliver radiation externally with high accuracy and precision makes this mode suitable for many types of cancer treatment. All these factors are likely to contribute towards the substantial market share of the segment

Based on Procedure, the particle therapy segment, accounted for the highest growth rate in the external beam radiotherapy industry, during the forecast year

The external beam radiotherapy segment is segmented into Image-Guided Radiation Therapy (IGRT), Intensity-Modulated Radiation Therapy (IMRT), particle therapy, stereotactic therapy, and 3D Conformal radiotherapy. The particle therapy segment is expected to register the highest growth rate during the forecast period attributed to growing adoption of proton therapy by many cancer facilities, the ability to deliver high higher dose of radiation to tumour cells with reduced impact on surrounding cells, expansion of proton therapy centers worldwide, and rising number of research activities in the filed of proton therapy.

To know about the assumptions considered for the study, download the pdf brochure

North America to account for the largest share of the radiotherapy industry during the forecast period.

North America is the expected to be the largest region for radiotherapy market during the forecast period. Countries in this market are witnessing a high number of cancer patients undergoing radiation therapy procedures, presence of well-established healthcare facilities, favourable reimbursement policies, and strong foothold of market players in the region.

As of 2022, prominent players in the radiotherapy market are Siemens Healthcare GmbH (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA (Belgium), ViewRay Technologies, Inc. (US), among others.

Scope of the Radiotherapy Industry

This report has segmented the global radiotherapy market to forecast revenue and analyze trends in each of the following submarkets:

By Type

• Product
• Software & Service

By Technology

• External Beam Radiotherapy
  • Linear Accelerators
    • Conventional Linear Accelerators
    • MRI LINAC
    • Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
    • Gamma Knife
    • CyberKnife
    • TomoTherapy
  • Conventional Cobalt-60 Teletherapy Units
  • Particle Therapy Systems
    • Cyclotrons
    • Synchrotrons
    • Synchrocyclotron
• Internal Beam Radiotherapy/Brachytherapy
  • Seeds
  • Afterloaders
  • Applicators
  • IORT Systems
• Systemic Radiotherapy
  • Iobenguane (I-131)
  • Samarium-153
  • Rhenium-186
  • Other Systemic Radiotherapy Products*

Note:*Other systemic radiotherapy products include Yttrium-90, Radium-223, Phosphorous-32, and Radio-labelled Antibodies, among others.

By Application

• External Beam Radiotherapy
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Colorectal Cancer
  • Other Cancers*
• Internal Beam Radiotherapy/Brachytherapy
  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Cervical Cancer
  • Penile Cancer
  • Other Cancers**

Note 2: *Other cancers in external beam radiotherapy applications include spine, brain, and pediatric cancer, among others.

Note 3:**Other cancers in internal beam radiotherapy applications include lung and head & neck cancer, among others.

By Procedure

• External Beam Radiotherapy
  • Image-guided Radiotherapy
  • Intensity-modulated Radiotherapy
  • Stereotactic Therapy
  • Particle Therapy
  • 3D Conformal Radiotherapy

• Internal Beam Radiotherapy/Brachytherapy
  • High-dose-rate Brachytherapy
  • Low-dose-rate Brachytherapy
  • Pulsed-dose-rate Brachytherapy
• Systemic Radiotherapy
• Intravenous Radiotherapy
• Oral Radiotherapy
• Instillation Radiotherapy

By End User

• Hospitals
• Independent Radiotherapy Centers

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • RoAPAC
• Latin America
  • Brazil
  • Mexico
  • RoLATAM
• Middle East & Africa

Recent Developments of Radiotherapy Industry

• In October 2023, Accuray incorporated received approval of Tomo C radiation therapy system by the Chinese National Medical Products Administration (NMPA).
• In July 2023, IBA entered into partnership with Apollo Proton Cancer Centre (APCC) (India) to provide training to Oncologist on proton beam therapy
• In April 2022, Elekta and GE Healthcare entered into a global commercial collaboration agreement in the field of radiation oncology, enabling them to provide hospitals a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst